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Background and Purpose: Progressive supranuclear palsy (PSP) is a rare
neurodegenerative disease clinically characterized by prominent axial extrapyramidal
motor symptoms with frequent falls. Over the last years the introduction of robotic
technologies to recover lower limb function has been greatly employed in the
rehabilitative practice. This observational trial is aimed at investigating the changes
in the main spatiotemporal following end-effector robot training in people with PSP.
Method: Pilot observational trial.
Participants: Five cognitively intact participants with PSP and gait disorders.
Interventions: Patients were submitted to a rehabilitative program of robot-assisted
walking sessions for 45min, 5 times a week for 4 weeks.
Main outcome measures: The spatiotemporal parameters at the beginning (T0) and at
the end of treatment (T1) were recorded by a gait analysis laboratory.
Results: Robot training was feasible, acceptable and safe and all participants completed
the prescribed training sessions. All patients showed an improvement in the gait
spatiotemporal index (Mean velocity, Cadence, Step length, and Step width) (T0 vs. T1).
Conclusions: Robot training is a feasible and safe form of rehabilitation for cognitively
intact people with PSP. The lack of side effects and the positive results in the gait
parameter index in all patients support the recommendation to extend the trials of this
treatment. Further investigation regarding the effectiveness of robot training in time is
necessary.
Trial registration: ClinicalTrials.gov NCT01668407.
Keywords: progressive supranuclear palsy, PSP, gait analysis, lower limb, robot
INTRODUCTION
Progressive supranuclear palsy (PSP) is a rare neurodegenerative
disease that causes the gradual deterioration and death of spe-
cific volumes of the brain (Richardson et al., 1963; Steele et al.,
1964). Ludolph and colleagues showed that the neuropathologic
features of PSP include marked midbrain atrophy and atrophy of
the pallidum, thalamus, subthalamic nucleus, and frontal lobes
(Ludolph et al., 2009). Clinical criteria for the diagnosis of PSP
are: a gradually progressive disorder, an onset at the age of 40
years or later, a presence of vertical supranuclear palsy, a slow-
ing of vertical saccades and a postural instability with falls in the
first year of disease onset. In particular, the first symptoms in
two-thirds of the cases are: loss of balance, lunging forward when
mobilizing, fast walking, bumping into objects or people, and
falls (Lubarsky and Juncos, 2008). Other common early symp-
toms are changes in personality, general slowing of movement
and visual symptoms. Postural instability and gait impairment are
the most important disorders in the early phases of the disease.
The PSP subject shows a short, shuffling stepped gait, gait freez-
ing, lurching, unsteady gait or spontaneous falls (Lubarsky and
Juncos, 2008). In particular, subjects with PSP have decreased
step length, step velocity, and a significantly slower ability to
break a fall from the center of gravity than controls (Welter et al.,
2007). Although some disorders are similar to those found in
Parkinsonism (rigidity, bradykinesia, postural instability), PSP
differs in several ways. The PSP subject does not have a forward
flexed posture like the Parkinson Disease (PD) subject and falls
in PSP tend to be backwards (Boeve, 2007). Pharmacotherapy
with carbidopa/levodopa and with dopamine agonists typically
is ineffective in managing the disorders (Rampello et al., 2005).
Non-pharmacologic therapies such as physical therapy and occu-
pational therapy are potentially useful, with the main goals being
the maintenance of functional ambulation and the reduction of
falls and associated injuries (Steffen et al., 2007). Gait recovery
in all patients with impairments of the central nervous system
(CNS) is an integral part of rehabilitation and often influences
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the possibility of a patient returning home or to work (Schmidt
et al., 2007). Neurologic motor rehabilitation is directed toward
the re-learning of motor skills. In particular, the recovery of walk-
ing is a crucial aspect of rehabilitation, improving the quality
of life and patient’s independence. For non-ambulatory neuro-
logical patients, mechanically assisted walking with body weight
support (BWS) has been suggested as a strategy to facilitate walk-
ing (Richards et al., 1993; Hesse et al., 2001) because it provides
the opportunity to complete more practice of the whole task
than would be possible by assisting overground walking. In the
last years, robot-aided walking is considered a promising tool
for gait rehabilitation (Colombo et al., 2000) in various neu-
rological disease (Beer et al., 2008; Lo and Triche, 2008; Hesse
et al., 2010). The robotic devices have been developed to relieve
physical therapists from the strenuous and not ergonomic bur-
den of manual BWS (Volpe et al., 2001; Winchester and Querry,
2006; Steffen et al., 2007). Furthermore, the use of robotic devices
is currently advised to prevent the risk of falls and to improve
gait velocity with the total safety of the patient (Morone et al.,
2014). Moreover, robot devices can be used to give inpatients
an intensive program (in terms of many repetitions) of complex
gait cycles. The robotic machines, offering practice up to 1000
steps per session, used either an exoskeleton or an end-effector
approach. Currently, a robotic task-specific repetitive approach,
i.e., numerous practices of complex gait cycles, is regarded as the
most promising to restore motor function after neurological dis-
ease (Dobkin, 2004; Dobkin and Duncan, 2012). Evidence-based
approaches of rehabilitation in PSP are lacking and currently the
majority of research on these subjects consists of case reports
involving only a small number of patients. Until now, only few
studies have been carried out on physiotherapy intervention in
the PSP gait and balance disorder (Izzo et al., 1986; Sosner et al.,
1993; Suteerawattananon et al., 2002; Steffen et al., 2014). Usually
the subject with PSP needs rehabilitative training to improve bal-
ance and gait problems and to prevent the frequent falls. The
rehabilitation programs for patients with PSP generally include
limb-coordination activities, tilt-board balancing, gait training,
strength training with progressive resistive exercises and isoki-
netic exercises and stretching of the neck muscles (Miyai et al.,
2002). Even if several studies have demonstrated the efficacy
of workout, including treadmill training, in subjects with PD
(Zampieri and Di Fabio, 2006; Semprini et al., 2009; Mehrholz
et al., 2010), so far little evidence has been found on the effects
of the treadmill training therapy on tauopathies or other parkin-
sonian disorders (Suteerawattananon et al., 2002; Steffen et al.,
2007) and no study has been conducted on the employment of
robot assisted treatment in PSP subjects. This study was aimed
at investigating the effects on improvement of the walking func-
tion by a change in spatiotemporal parameters using end-effector
robotic rehabilitation locomotion training in patients with PSP.
MATERIALS AND METHODS
This study was a pilot observational trial. The subject had been
on stable doses of medication for at least 4 weeks prior to study
onset and showed an endurance sufficient to keep an upright
position, assisted or unassisted, for at least 15min. A preliminary
medical examination included a physical and neurological test
besides a gait analysis. The inclusion criteria for all groups
were: (a) diagnosis of idiopathic PSP according to the UK Brain
Bank criteria, without any other significant neurological or
orthopaedic disorder; (b) age between 18 and 90 years old; (c)
ability to walk, unassisted or with little assistance, for at least 25
feet. The following exclusion criteria were identified: (d) inability
to understand instructions required by the study (Informed
Consent Test of Comprehension); (e) primarily wheelchair
bound; (f) chronic and ongoing alcohol or drug abuse, active
depression, anxiety or psychosis that might interfere with the use
of the equipment or testing.
INSTRUMENTAL ASSESSMENTS
Trained professionals, who were not involved in the research
treatment and blind to patients’ treatment, performed all instru-
mental and clinical assessments. All outcome assessments were
collected in the ON phase 1 h and half after oral assumption of
the usual dose of medication. The 3D-Gait analysis (3D-GA) was
conducted using the following equipment: a 12-camera opto-
electronic system with passive markers (ELITE2002, BTS, Italy)
to measure the kinematics of the movement; 2 force platforms
(Kistler, CH) to obtain the kinetic data of the movement (i.e.,
ground reaction forces); 2 TV camera Video systems (BTS, Italy)
synchronized with the optoelectronic and force platform systems
for video recording. To evaluate the kinematics of each body
segment, markers were positioned as described by Davis and
colleagues (Sale et al., 2012, 2013a). Subjects were asked to walk
barefoot, at their own natural pace (self-selected and comfortable
speed), along a 10-meter walkway where the two force platforms
were placed. At least seven trials were collected for each subject
in order to ensure data consistency. All graphs obtained from GA
were normalized as a % of the gait cycle and kinetic data were
normalized for individual body weights. In order to quantify
the gait pattern of participants involved in this study, a specific
software (Smartanalyser, BTS, Italy) enabled the calculation of
some indices (time/distance parameters, joint angles values in
specific gait cycle instant, peak values in ankle power graph)
starting from those data.
PRIMARY OUTCOMES
A primary outcome was the change in spatiotemporal parame-
ter. In particular we recorded: the gait velocity assessed by mean
velocity (m/s), which measured the rate of change of position,
recorded in meters per second; the cadence (step/min) that mea-
sured the number of steps taken in a given period of time, which
was then converted into the number of steps taken per minute;
the step length (mm) that measured the average distance (mm)
between two successive placements of the same foot; the stride
length (mm) that measured the average distance (mm) between
two successive placements of the same foot, the step width (mm)
that measured the medio-lateral distance between the two feet
during double support; the stance time (stride %) that measured
the duration of the stance phase; the swing time (stride %) that
measured the duration of the swing phase and the double support
(stride %) that measured the duration of double support.
ROBOT THERAPY
Each subject was asked to perform 20 sessions (5 days a week for
4 weeks) of robot assisted gait training, using the commercially
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available end effector systemmachines G-EO system device (Reha
Technology AG; Olten, Switzerland). The trajectories of the foot-
plates and the vertical and horizontal movements of the center
of mass were fully programmable, enabling wheelchair-bound
subjects not only the repetitive practice of simulated floor walk-
ing but also up and down stair climbing. One therapist, who
has experience in machine-supported gait rehabilitation, assisted
the patients with putting on the harness while sitting in their
wheelchair, getting onto the G-EO System in the wheelchair using
a ramp from the rear, fixing the feet on the plates, hoisting the
patient, attaching the lateral ropes, and setting the therapy param-
eters memorized by the G-EO System computer. The footplates
had 3 DoF each, allowing to control the length and the height
of the steps and the foot plate angles. The maximum step length
corresponded to 550mm, the maximum achievable height of the
steps was 400mm and themaximum angles were±90◦. The max-
imum speed of the foot plates was 2.3 km/h. The exercise included
a robot-assisted walking therapy, at variable speeds, for a maxi-
mum of 45min, with a partial BWS. All participants started with
30–40% of BWS and an initial speed of 1.5 km/h; speed was then
increased to a range of 2.2–2.5 km/h maximum and initial BWS
was decreased. Two further DoF controlled the BWS system and
the lateral displacement of the hip. The graphic user interface
(GUI) showed during the training the actual trajectory, so that the
therapists were able to control and to correct it. Changes during
the training were made for step length, step height, the termi-
nal stance and the initial contact inclination angles of the feet,
the vertical and the lateral excursions of the CoM, and for the
relative position of the suspension point with respect to the foot-
plates. The computer saved the trajectory settings. The adaptive
control was applied only to both of the 3 DoF intended to con-
trol the legs. The remaining 2 DoF for the control of the center of
mass were excluded from being master in the adaptive mode. In
particular, the patients must apply the necessary force for mov-
ing the footplates along the selected trajectory. The necessary
force for moving the footplates along the selected trajectory set-
tings was set by a force level slider in the software of the robot.
The computer put the footplates and the mechanics of the G-EO
Systems to virtual zero friction and once the intended force level
on the lower limb was reached, there could be amplification to
the movement, according to the value of the amplification level
selected in the robot by therapist. The amplification level pro-
vided for additional acceleration while executing the movement
of the footplates along the selected trajectory. By adding acceler-
ation to the necessary force for moving, the footplates lowered.
This provided a smooth and continuous movement of the foot-
plates. After 45min the session was stopped. During each session,
the patients practiced 5–30min of simulated floor walking fol-
lowed by 5 to 10min of repetitive simulated stair climbing up and
down. The patient practiced a minimum of 300 steps on the sim-
ulated floor and climbed a minimum of 50 steps on the simulated
stair during each session. Breaks were optional, but uninterrupted
training intervals of at least 5min for simulated floor walking
and 3min of simulated stair climbing were required. Heart rate
and blood pressure were monitored at the beginning and at the
end of each session. Subjects who did not retrieve sessions and
interrupted the treatment for more than 3 consecutive days were
excluded from the study.
STATISTICAL ANALYSIS
All the previously defined parameters were computed for each
participant. Mean values and standard deviations of all indexes
were calculated for each group. The Kolomogorov–Smirnov tests
were used to verify if the parameters were normally distributed. As
this was not the case, we used Wilcoxon’s tests in order to detect
significant changes between data at baseline (T0) and endpoint
(T1). The T0 and T1 data of all patients and CG were compared
with Mann-Whitney U tests. Statistical significance was set at
p < 0.05. The Mann-Whitney test was used to compare median
scores between groups.
ETHICAL ASPECTS
This study was performed in accordance with the Declaration of
Helsinki and was approved by the ethics committees of IRCCS
San Raffaele Pisana. Informed consent was obtained from all
subjects enrolled in this study.
RESULTS
We screened 15 patients, 5 of whom satisfied the inclusion cri-
teria. No dropouts were recorded during the treatment and all
subjects fulfilled the protocol (compliant subjects: N = 5). The
distribution of the study subjects (N = 5) by age, gender, and
main clinical and demographical characteristics are shown in
Table 1. The median age was 67.80 ± 11.71 years. Participant
demographics are presented in Table 1. Table 2 summarizes the
observed mean ± SD for all tests (T0 vs. T1), as measured on
the compliant subjects at T0 (N = 5), T1 (N = 5) (Table 2). Gait
velocity (T0 0.54 ± 0.173m/s and T1 0.69 ± 0.150m/s) and
cadence (T0 83.00 ± 9.618 and T1 93.60 ± 15.437) improved
respectively by 15 and 23.8%. Participants also demonstrated an
improvement of 11% in step length left (T0 421.00 ± 98.831mm
and T1 466.40± 105.749mm) and of 35% in step length right (T0
363.20± 94.767mm and T1 429.80± 67.570mm) and a decrease
of 9% of Step width (T0 166.60 ± 24.460mm and T1 153.60 ±
43.678mm) (Table 2). Due to a small analyzed sample size no
statistical significance was found in all the analyzed parameters.
No significant changes were found in SpO2 (T0 97.5 ± 1.6 T1 97
± 4.1, and in the HR (T0 82.3 ± 13.1 T1 86.9 ± 16) after the
trainings in all patients. The patients workload and statisfaction
Table 1 | Patients’ clinic and demographic data at baseline.
Experimental group (n = 5)
n Mean ± SD
Dropout 0
Compliants 5
Male 3
Female 2
Age 67.8 ± 11.7
Height 161.2 ± 3.56
Weight 72.00 ± 10.58
Years of disease 3.6 ± 1.85
Psp rating scale 32.00 ± 9.24
PSP staging scale 2.4 ± 0.5
Walking handicap scale 3.2 ± 1.48
Legend n, number; SD, standard deviation
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assessed by a Visual Analogical Scale showed a tendency toward
positive feelings regarding the training process. Moreover regard-
ing the fatigue the patients reported that during and at the end of
the training training there was no excessive fatigue. The patients
did clearly feel safe and comfortable with the robot at the end of
the training.
DISCUSSION
Many authors have shown the efficacy of robot-assisted gait train-
ing on improving the walking function in several neurological
diagnoses (Wirz et al., 2005; Morone et al., 2012; Schwartz et al.,
2012; Sale et al., 2013a) but the process aimed at restoring this
function in patients with a neurological pathology is challenged
by the complexity and variability of these disorders (Sale et al.,
2012). As far as we know, this is the first study that examines
the effects of end effector robot-assisted training in individu-
als with PSP. This study shows that twenty 45-min sessions of
robot-assisted training is a treatment that could stimulate and
enhance the beneficial effects of motor training on gait recov-
ery in patients with PSP. This trial protocol is easy, reproducible
and safe and it allows the training of PSP subjects with moder-
ate to severe lower limb impairment. As demonstrated, in gait
training to walk repetitively in a natural manner similar to the
over-ground gait and with the correct proprioceptive and exte-
roceptive feedback is of the most critical importance (Sale et al.,
2012). In particular our adaptive training robotic protocol where
the patient interacts with the robot can overcome all the limita-
tions about the repetitively (and repeatability) of the movement
with respect to the human-human interaction. Until now, sev-
eral studies have demonstrated that robotic gait training can slow
the clinical progression of gait disease in PD patients, but so
far, no other evidence has been found in the PSP population.
In particular, robot-assisted training may improve postural insta-
bility in patients with PD (Picelli et al., 2012a) or may develop
aspects of walking ability (Picelli et al., 2012b). In our recent
paper we demonstrated that the use of the end-effector lower limb
robotic device in PD patients increases a short period lower limb
motor recovery in idiopathic PD patients, improving above all
the gait velocity, the step length and the stride length (Sale et al.,
2013b). To date, there are not many studies on the gait reha-
bilitation in patients with PSP. Recently Steffen and colleagues
published an interesting case report on the use of the treadmill
in gait recovery in one patient with PSP, with a follow-up of
10 years. In particular, the author showed how a patient with
PSP participated consistently in a regular group exercise program
for 10 years and how he reduced fall frequency, maintained bal-
ance and endurance and retained community ambulation using
a walker (Steffen et al., 2014). Falls and the associated trauma
are one of the main causes of morbidity and mortality in these
disorders and the lower limb training could effectively prevent
it; falls are also the leading cause of unintentional injury and
hospitalization in people aged 65 years and older (Dellinger and
Stevens, 2006; Bridenbaugh and Kressig, 2011). Different meth-
ods of gait rehabilitation have been used so far in neurological
lower limb physiotherapy to prevent the falls, such as manu-
ally assisted over-ground training and manually assisted treadmill
training or robotic training with or without the BWS (Sale et al.,
2012). The advantage of these electromechanical devices, com-
pared with treadmill training with partial BWS in PD and Stroke
patients, may be the reduced effort required by therapists, as they
no longer need to set the paretic limbs or assist trunk movements
(Hesse et al., 2003). However, the effort in the development of
robotic gait training is not limited to the improvement of work-
ing conditions of physiotherapists, but rather in providing the
patient with an engaging, challenging and effective rehabilitation
tool. Our choice to use the robotic device in PSP gait recovery
has many bases. Our training shows in all patients an improve-
ment in each spatio-temporal parameter, in particular cadence,
step length, stride length, velocity, and reduction of step width.
These are the parameters mostly connected to the risk of falls. In
particular, several studies have identified changes in certain spa-
tial and temporal gait parameters as independent predictors of the
fall risk. Tailored and colleagues showed in a sample of older peo-
ple that there were significant main effects of gait condition and of
faller status for mean value measures (velocity, stride length, dou-
ble support time, and stride width) and for variability measures
(swing time variability and stride length variability); the exam-
ination of individual gait parameters indicated that the multiple
fallers walkedmore slowly, had a shorter stride length, spent more
time in double support, had a wider support width and showed
more variability in stride length and swing time (Taylor et al.,
2013). Maki observed in his study that increased stride-to-stride
variability in stride length, stride speed and double support time
as well as increased stride width were predictive of falls in the
ensuing 6 months for residents of a senior living facility (Maki,
1997). Our data, compared with the results of Tailored and Maki,
suggest that the robot therapy, with the intention to recover the
leg movements, could increase and help these patients to pre-
vent falls and other trauma. Several conditions should however be
considered when interpreting these data. Most importantly, these
are simply case descriptions. Changes in these 5 individuals could
have been due to a variety of factors. Possibly the improvements
could represent progresses in test performance. Or perhaps the
observed changes could be due to usual day-to-day, but it should
be noted that the trends in the repeated measures were fairly con-
sistent and showed improvement in all patients. A long period
follow-up is required to confirm our hypothesis. Furthermore,
it is unknown to what extent these findings will generalize in
other individuals in the early and middle stages of PSP. These 5
individuals were in the early to middle stages of PSP and highly
motivated, which may have contributed to their reported adher-
ence, even after completing the supervised part of the program.
Our experience and various examined articles showed that robot-
assisted gait therapy provides versatile control approaches as a
framework in the design of optimal rehabilitation interventions
and experimental motor control studies, but the high cost of
robot devices raises the question of efficiency in comparison with
other training strategies.
CONCLUSION
The focus on gait recovery represents one of the most innovative
features of this study and makes this research useful in clinical
practice. Spatial-temporal gait analysis can detect discrete gait dis-
orders, which are not perceptible to the naked eye, and several
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gait changes have been identified as fall predictors. Early detection
allows early intervention. The positive results on improvement
in spatiotemporal parameter of the PSP subject by the Robot
Therapy, the lack of side effects strongly recommend extending
the use of a Robot Therapy in the recovery of gait performance.
This rehabilitation training could provide new opportunities in
PSP rehabilitation thanks to a sensorimotor approach aimed at
functional recovery.
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